TSTae-Seok Seo

Tae-Seok Seo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tae-Seok Seo has a total of 90 co-authors. Here are the top co-authors by number of shared publications:

  • Myung Gyu Song

    Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine , Seoul, Republic of Korea

    12 shared publications
  • Myung Gyu Song

    Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea

    11 shared publications
  • Woo Jin Yang

    Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea University, Seoul 08308, Republic of Korea

    6 shared publications
  • In-Ho Cha

    Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea

    4 shared publications
  • Sung-Joon Park

    Department of Radiology, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Korea

    4 shared publications
  • Hwan Hoon Chung

    Department of Radiology, Korea University Ansan Hospital, Ansan, Gyeonggi-do, South Korea

    3 shared publications

Latest Publications

  • Open Access

    Single-Incision Technique for Placement of Totally Implantable Venous Access Port via the Axillary Vein

    by Woo Jin Yang, Myung Gyu Song, Tae-Seok Seo

    Korean Journal of Interventional Radiology

  • Open Access

    Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair: A Target Trial Emulation

    by Ki Hong Choi, Danbee Kang, Jihee Nam, Take Kyu Park, Myung Gyu Song, Tae‐Seok Seo, Woo Jin Yang, Seung‐Hyuk Choi

    Background: The optimal antiplatelet regimen after standard endovascular aneurysm repair (EVAR) in patients without atherosclerotic cardiovascular disease remains uncertain. Clinical guidelines offer limited recommendations, and data specific to this population are sparse. This study aimed to compare the efficacy and safety of single versus dual antiplatelet therapy (DAPT) in patients undergoing standard EVAR for abdominal aortic aneurysms without established atherosclerotic cardiovascular disease. Methods: This study emulated a target trial using the Korean National Health Insurance Service database, which includes the entire Korean population. We identified all patients who underwent standard EVAR between January 2003 and September 2023 and excluded those with atherosclerotic cardiovascular disease or no antiplatelet therapy. Patients were categorized by discharge medication into single antiplatelet therapy or DAPT groups. The primary cardiovascular efficacy end point was major adverse cardiac and cerebrovascular events (all‐cause death, myocardial infarction, or ischemic stroke). The EVAR‐specific efficacy end point was abdominal aortic aneurysm reintervention or surgery. The safety end point was major or clinically relevant nonmajor bleeding. Inverse probability treatment weighting was applied to adjust baseline differences. Results: Among 8325 patients, 4162 (50.0%) received single antiplatelet therapy (80.6% aspirin, 19.4% clopidogrel), and 4163 (50.0%) received DAPT (aspirin plus clopidogrel). There were no significant differences between single antiplatelet therapy and DAPT in the risk of major adverse cardiac and cerebrovascular events (inverse probability treatment weighting‐hazard ratio [HR], 1.07 [95% CI, 0.93–1.22]) or abdominal aortic aneurysm reintervention/surgery (inverse probability treatment weighting‐HR, 1.07 [95% CI, 0.92–1.24]). However, DAPT was associated with a higher risk of major or clinically relevant nonmajor bleeding (inverse probability treatment weighting‐HR, 1.20 [95% CI, 1.02–1.41]). Conclusions: In patients without atherosclerotic cardiovascular disease undergoing standard EVAR, DAPT did not confer cardiovascular or procedural benefit but was associated with increased bleeding. Single antiplatelet therapy may represent a safer and equally effective antiplatelet strategy in this population. Registration: URL: https://clinicaltrials.gov ; Unique Identifier: NCT06876727.


  • Open Access

    Successful plug-assisted retrograde transvenous obliteration via the right gonadal vein for duodenal variceal bleeding from a mesocaval shunt

    by Woo Jin Yang, Tae-Seok Seo, Myung Gyu Song

    Woo Jin Yang, Tae-Seok Seo, and Myung Gyu Song. Int J Gastrointest Interv 2025;14:124-7. https://doi.org/10.18528/ijgii250032


  • Safety of 3-month flushing interval for prevention of occlusion in totally implantable venous access ports: An analysis focused on intraluminal clots

    by Woo Jin Yang, Myung Gyu Song, Tae-Seok Seo, Danbee Kang, Sung-Joon Park, Jung Won Kwak

    Background: This study aimed to assess the safety and feasibility of a 3-month flushing interval for totally implantable venous access ports (TIVAPs), particularly regarding intraluminal clot formation. Methods: Between May 2017 and September 2018, we established a single-center cohort of 151 patients who were referred for TIVAP removal and categorized them into three flushing-interval groups: A (⩽1 month), B (1–2 months), and C (2–3 months). Odds ratios (OR) with 95% confidence intervals (CI) were computed using logistic regression to determine the risk of intraluminal clot occurrence. To compare clot lengths among the groups, we employed linear regression. Restricted cubic splines were used to model the flushing interval as a continuous variable. Results: Compared to Group A, Groups B and C had adjusted ORs of 0.82 (0.35–1.92) and 0.78 (0.29–2.11) for intraluminal clot risk. Occlusion was rare (1/151; 0.7%) and successfully treated with mechanical recanalization. Adjusted differences in clot length compared to Group A were 0.01 (−0.85 to 0.87) for Group B and −0.23 (−1.21 to 0.76) for Group C. Spline regression analysis showed no significant association between the flushing interval and clot length ( p for trend = 0.84). Conclusion: The incidence and burden of intraluminal clots did not increase significantly within the first 3 months. Occlusion was rare, even in the presence of clots, and was successfully treated. Therefore, a 3-month flushing interval appears to be a safe and practical option, aligning with the common recommendation for surveillance intervals in patients with cancer.


  • Open Access

    Association between uterine artery embolization for postpartum hemorrhage and second delivery on maternal and offspring outcomes: a nationwide cohort study

    by Woo Jin Yang, Danbee Kang, Ji-Hee Sung, Myung Gyu Song, Hyejeong Park, Taegyun Park, Juhee Cho, Tae-Seok Seo, Soo-Young Oh

    STUDY QUESTION: What are the maternal and neonatal outcomes of second delivery in women who underwent uterine artery embolization (UAE) during their first delivery? SUMMARY ANSWER: Women who underwent UAE during their first delivery exhibited higher risks of placental problems, preterm births, and postpartum hemorrhage (PPH) in second delivery and the second offspring also showed increased risk of major congenital malformations, admission to the neonatal intensive care units (NICU), necrotizing enterocolitis, intraventricular hemorrhage, and bronchopulmonary dysplasia. WHAT IS KNOWN ALREADY: UAE is a minimally invasive procedure used as an alternative to hysterectomy for managing severe PPH. However, recent studies have raised concerns about potential obstetric complications, including recurrent PPH, placenta accreta spectrum (PAS), and fetal growth restriction in subsequent delivery following UAE. STUDY DESIGN, SIZE, DURATION: This was a nationwide retrospective cohort study using the Korean National Health Insurance Service (K-NHIS) database, covering 50 million individuals from 2004 to 2020. The cohort included 3 616 923 women with live births between 1 January 2005 and 31 December 2019 with follow-up data extending to 31 December 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included women who had their first live birth between 2005 and 2019, excluding those who underwent hysterectomy (without UAE = 3 612 389, UAE = 4534). Among them, we selected women who had single gestation secondary delivery (without UAE = 1 694 600, UAE = 1146). Propensity score matching was used to control for confounding factors, resulting in 11 184 women without UAE and 1119 women with UAE for subsequent analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Women in the UAE group had significantly higher risks of PAS (odds ratio (OR) = 38.91, 95% CI = 18.61–81.34), placenta previa (OR = 6.98, 95% CI = 5.57–8.75), and preterm birth (OR = 2.23, 95% CI = 1.71–2.90) during their second delivery. The risk of recurrent PPH was also significantly higher (OR = 8.94, 95% CI = 7.19–11.12). Their second offspring were more likely to have major congenital malformations (OR = 1.62, 95% CI = 1.25–2.11) and adverse neonatal outcomes, including NICU admissions (OR = 1.83, 95% CI = 1.48–2.25). Long-term outcomes showed a higher risk of attention-deficit/hyperactivity disorder (hazard ratio = 1.64, 95% CI = 1.03–2.63) but were otherwise comparable to those in the without UAE group. LIMITATIONS, REASONS FOR CAUTION: Retrospective nature of the study may have introduced exposure and outcome misclassifications, despite the reliability of the K-NHIS database. Unmeasured confounders and selection bias due to only including live births could also have influenced the results. WIDER IMPLICATIONS OF THE FINDINGS: Women with a history of UAE require meticulous prenatal care and close monitoring during subsequent deliveries due to increased risks of complications. Counseling and referral to high-risk medical centers may improve outcomes. Further research is needed to understand the mechanisms of complications in both mothers and offspring at sequential delivery, as well as to refine UAE procedures. STUDY FUNDING/COMPETING INTEREST(S): This study supported by Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health & Welfare, Republic of Korea (HC21C0123). This study was funded by S.-Y.O. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. TRIAL REGISTRATION NUMBER: N/A.


  • Open Access

    Feasibility and Safety of a Technique Intended to Place the Catheter Tip in the Right Atrium without Abutment Against the Cardiac Wall during Implantation of the Totally Implantable Venous Access Port

    by Hyejin Park, Tae-Seok Seo, Myung Gyu Song, Woo Jin Yang

    박혜진, et al. J Korean Soc Radiol. 2024 Jan;85(1):161-170. https://doi.org/10.3348/jksr.2023.0061


  • Open Access

    The Impact of Socioeconomic Status on Mortality in Patients with Hepatocellular Carcinoma: A Korean National Cohort Study

    by Woo Jin Yang, Danbee Kang, Myung Gyu Song, Tae-Seok Seo, Ji Hoon Kim

    Woo Jin Yang, Danbee Kang, Myung Gyu Song, Tae-Seok Seo, and Ji Hoon Kim. Gut and Liver 2022;16:976-84. https://doi.org/10.5009/gnl210567


  • Effectiveness of mechanical recanalization for intraluminal occlusion of totally implantable venous access ports

    by Woo Jin Yang, Myung Gyu Song, Tae-Seok Seo, Sung-Joon Park

    Purpose: To evaluate if the mechanical injection of saline is effective in restoring patency of a totally implantable venous access port (TIVAP) with an intraluminal occlusion. Materials and methods: From January 2017 to June 2019, 64 cases of dysfunction of a TIVAP were referred to interventional radiology. Among these, 16 cases showed normal function of the TIVAP, 19 cases the showed the appearance of a fibroblastic sheath, and 29 cases showed intraluminal occlusion. Mechanical recanalization was performed for intraluminal occlusion of the TIVAP with an indeflator and a 20G non-coring needle. Linograms were performed in all recanalized cases. The success or failure of recanalization and the pressure of the indeflator were recorded. Linograms were evaluated for breakage or migration of catheters. Medical records were retrospectively reviewed. Results: Among the 29 intraluminal occlusion cases, 24 cases (82.7%) were recanalized by mechanical recanalization via an indeflator. The pressure of the indeflator ranged from 29 to 220 psi (median: 118 psi). Linograms revealed breakage of the catheter of the TIVAP in two failed cases. The median interval from implantation to dysfunction was 405 days (range: 43–1723 days). The median interval from last use to dysfunction was 8 days (mean: 15.4 days; range: 1–119 days). The median re-occlusion free period after successful mechanical recanalization was 100.5 days (range: 6–859 days). Conclusion: In the absence of an available thrombolytic agent, mechanical injection of saline was a tolerable alternative method for restoring occluded catheters and sustaining the function of catheters. Because breakage of the catheter can occur during mechanical recanalization of a TIVAP, a linogram should follow the procedure.


  • The usefulness and feasibility of placing a clinch knot with a guidewire to achieve temporary hemostasis in arteriovenous dialysis access interventions

    by Sung-Joon Park, Hwan Hoon Chung, Seung Hwa Lee, Sung Beom Cho, Tae-Seok Seo, Myung Gyu Song

    Purpose: To evaluate the usefulness and feasibility of using a reversible clinch knot with a guidewire in place rather than eliminating the access route during an arteriovenous hemodialysis access (AV access) intervention using the facing sheath technique. Material and methods: From July 2016 to June 2019, we retrospectively studied 78 sessions performed as interventional treatment for arteriovenous (AV) hemodialysis (HD) access using the “facing-sheath technique.” In all sessions, all antegrade sheaths were removed while a 0.035-inch guidewire remained in place with purse-string suture and the clinch knot. Seventy-two sessions were performed in patients with thrombosed AV accesses (69 arteriovenous grafts [AVGs] and three arteriovenous fistulas [AVFs]), and six sessions were carried out to treat non-thrombosed AV accesses (four AVGs and two AVFs). We evaluated whether proper hemostasis and successful reinsertion of the sheath over the wire into the clinch knot was achieved. Clinical success was defined as achieving prompt restoration of blood flow for AV access, and the postintervention primary and secondary patency were also evaluated. Result: In all 87 clinch knots created in 78 total sessions, proper hemostasis was achieved. All clinch knots that required reversal for additional procedures were successfully reopened (55 clinch knots in 50 sessions). The postintervention primary patency rates at 1, 3, and 6 months, and at 1 year were 77.8%, 68.9%, 55.6%, and 33.3%, respectively. The postintervention secondary patency rates at 1, 3, and 6 months, and also at 1 year were 93.3%, 91.1%, 86.7%, and 86.7%, respectively. Conclusion: Our AV access intervention which used a clinch knot with purse-string suture while the guidewire remained in place was both useful and feasible for maintaining temporary hemostasis.


  • Open Access

    Basic Arterial Anatomy and Interpretation of CT Angiography for Intra-Abdominal or Gastrointestinal Bleeding: Correlation with Conventional Angiographic Findings for Beginners

    by Dong Yoon Han, Ji Hye Hwang, Hye Jin Kang, Jehong Yoon, Se Hwan Kwon, Tae-Seok Seo, Joo Hyeong Oh

    It is essential to identify the causative artery in case of active intra-abdominal or gastrointestinal bleeding. A thorough understanding of the basic arterial anatomy is required to identify the causative artery on contrast-enhanced CT angiography and conventional catheter angiography. If one is familiar with the basic arterial anatomy, obtaining access to the bleeding artery will be easier, despite the variations in the origin and course of the vessels. We describe the basic arterial anatomy that will help beginners in diagnostic radiology to identify the blood vessels that can cause active intra-abdominal or gastrointestinal bleeding.